10 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.
Hedge Fund - Biotechnology Value Fund / BVF Inc
Get Email AlertsMark Lampert Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Biotechnology Value Fund / BVF Inc |
| Manager | Mark Lampert |
| Portfolio Value | $2,499,882,000 |
| Change This QTR | +0.91% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | Gh Research Plc | 9,275,158 | $169,643 | 6.78% | |||
| 2. | KYMR | 3,586,658 | $151,787 | +13% | 6.07% | ||
| 3. | RLAY | 4,530,605 | $135,601 | +45% | 5.42% | ||
| 4. | RCUS | 3,960,948 | $125,008 | +17% | 5% | ||
| 5. | MRUS | 4,135,071 | $109,331 | 4.37% |
News, Interviews and Investor Letters
10 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
13G Filing: Biotechnology Value Fund LP and Forward Pharma A/S (FWP)
Forward Pharma A/S (NASDAQ:FWP): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund LP and Erytech Pharma SA (ADR) (ERYP)
Erytech Pharma SA (ADR) (NASDAQ:ERYP): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund LP and Glycomimetics Inc (GLYC)
Please follow Biotechnology Value Fund LP (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Biotechnology Value Fund LP or update its stock holdings...
13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)
Cytokinetics Inc (NASDAQ:CYTK): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund LP and Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals Inc (NASDAQ:SNDX): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund LP and Spero Therapeutics Inc (SPRO)
Spero Therapeutics Inc (NASDAQ:SPRO): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund LP and Arqule Inc (ARQL)
Arqule Inc (NASDAQ:ARQL): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund L P and Arqule Inc (ARQL)
Arqule Inc (NASDAQ:ARQL): Mark Lampert's Biotechnology Value Fund LP filed an amended 13D.
You can check out Biotechnology Value Fund LP's latest holdings and filings here.
13G Filing: Biotechnology Value Fund LP and Spring Bank Pharmaceuticals Inc (SBPH)
You can access the original SEC filing by clicking here.
13D Filing: Biotechnology Value Fund LP and BioLineRX Ltd. (BLRX)
You can access the original SEC filing by clicking here.
13G Filing: Biotechnology Value Fund LP and Contrafect Corp (CFRX)
You can access the original SEC filing by clicking here.
13G Filing: Biotechnology Value Fund LP and Alpine Immune Sciences Inc. (ALPN)
You can access the original SEC filing by clicking here.
13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here.
